William Blair International Ldrs R6 WILJX

Medalist Rating as of | See William Blair Investment Hub
  • NAV / 1-Day Return 21.15  /  +0.62 %
  • Total Assets 1.2 Bil
  • Adj. Expense Ratio
    0.850%
  • Expense Ratio 0.850%
  • Distribution Fee Level Above Average
  • Share Class Type Retirement, Large
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.46%
  • Turnover 50%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0

Morningstar’s Analysis WILJX

Will WILJX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

William Blair International Ldrs R6’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings WILJX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS Class B

3.90 46.2 Mil
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd

2.77 32.9 Mil
Technology

AstraZeneca PLC

2.59 30.8 Mil
Healthcare

Reliance Industries Ltd

2.47 29.3 Mil
Energy

Hoya Corp

2.42 28.8 Mil
Healthcare

ASML Holding NV

2.33 27.7 Mil
Technology

London Stock Exchange Group PLC

2.31 27.5 Mil
Financial Services

Compass Group PLC

2.29 27.2 Mil
Consumer Cyclical

Icon PLC

2.24 26.6 Mil
Healthcare

MercadoLibre Inc

2.22 26.4 Mil
Consumer Cyclical

Sponsor Center